CY1108992T1 - Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας - Google Patents

Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας

Info

Publication number
CY1108992T1
CY1108992T1 CY20091100491T CY091100491T CY1108992T1 CY 1108992 T1 CY1108992 T1 CY 1108992T1 CY 20091100491 T CY20091100491 T CY 20091100491T CY 091100491 T CY091100491 T CY 091100491T CY 1108992 T1 CY1108992 T1 CY 1108992T1
Authority
CY
Cyprus
Prior art keywords
compositions
preparation
hyaluronic acid
oral
therapeutic treatment
Prior art date
Application number
CY20091100491T
Other languages
English (en)
Inventor
Franco Macchi
Original Assignee
Bioplax Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=30131290&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1108992(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bioplax Limited filed Critical Bioplax Limited
Publication of CY1108992T1 publication Critical patent/CY1108992T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Abstract

Η χρήση του υαλουρονικού οξέος ως το μοναδικό δραστικό συστατικό για την παρασκευή συνθέσεων ιδίως για τοπική χρήση για τη θεραπευτική αντιμετώπιση των αφθών της στοματικής κοιλότητας.
CY20091100491T 2003-06-25 2009-05-07 Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας CY1108992T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001291A ITMI20031291A1 (it) 2003-06-25 2003-06-25 Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
EP04766068A EP1638582B1 (en) 2003-06-25 2004-06-23 Use of hyaluronic acid for preparing compositions for treating recurrent oral cavity aphthas

Publications (1)

Publication Number Publication Date
CY1108992T1 true CY1108992T1 (el) 2014-07-02

Family

ID=30131290

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100491T CY1108992T1 (el) 2003-06-25 2009-05-07 Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας

Country Status (17)

Country Link
US (1) US10245280B2 (el)
EP (1) EP1638582B1 (el)
JP (1) JP4728955B2 (el)
CN (1) CN1812798B (el)
AT (1) ATE422892T1 (el)
BR (1) BRPI0411702B8 (el)
CA (1) CA2529441C (el)
CY (1) CY1108992T1 (el)
DE (1) DE602004019528D1 (el)
DK (1) DK1638582T3 (el)
ES (1) ES2322060T3 (el)
IT (1) ITMI20031291A1 (el)
MX (1) MXPA05014184A (el)
PL (1) PL1638582T3 (el)
PT (1) PT1638582E (el)
SI (1) SI1638582T1 (el)
WO (1) WO2005000321A1 (el)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1507543A4 (en) * 2002-05-09 2006-07-26 Cambridgemed Inc PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF WOOD WITH BLOOD PLASMA OR SERUM
US7323184B2 (en) * 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
ITMI20081450A1 (it) * 2008-08-04 2010-02-05 Biofarmitalia Spa Pellicola solida a rapida dissoluzione nei liquidi
IT1396468B1 (it) * 2008-11-11 2012-12-14 Farma Derma Srl Uso topico di acido ialuronico ad azione filmogena in preparati per il trattamento e profilassi di patologie delle vie respiratorie.
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
JP5840107B2 (ja) * 2012-06-17 2016-01-06 コスメディ製薬株式会社 ヒアルロン酸ゲル及びその製造方法
CN103860526A (zh) * 2013-11-26 2014-06-18 华熙福瑞达生物医药有限公司 一种含透明质酸的消毒剂、其制备方法及用途
EP3056195A1 (en) 2015-02-13 2016-08-17 Vision:Organic GmbH Compositions comprising hyaluronic acid and beta-glucan for topical applications in oral cavity
ITUB20153699A1 (it) * 2015-09-17 2017-03-17 Fastmeditalia Srl Integratore orale
IT201700048750A1 (it) * 2017-05-05 2018-11-05 Farm Procemsa S P A Composizione per il trattamento di afte e ulcere buccali
GB201713362D0 (en) * 2017-08-21 2017-10-04 Givaudan Sa Improvements in or relating to organic compounds
CN108210689A (zh) * 2017-11-27 2018-06-29 南京天纵易康生物科技股份有限公司 一种含有透明质酸的口腔溃疡膜剂及其制备方法
EP4230212A1 (en) 2022-02-16 2023-08-23 UNIVERSITÄTSmedizin der Johannes Gutenberg- Universität Mainz Composition and kits for the prevention or treatment of gum diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US183278A (en) * 1876-10-17 Improvement in ventilating-cowls
IT1240316B (it) 1990-02-21 1993-12-07 Ricerca Di Schiena Del Dr. Michele G. Di Schiema & C. Composizioni a base di acido ialuronico ad alto peso molecolare somministrabili per via topica per il trattamento di infiammazioni del cavo orale ,per la cosmetica e l'igiene del cavo orale
US5972906A (en) * 1991-07-03 1999-10-26 Hyal Pharmaceutical Corporation Treatment of mucous membrane disease, trauma or condition and for the relief of pain thereof
US6828308B2 (en) * 2000-07-28 2004-12-07 Sinclair Pharmaceuticals, Ltd. Compositions and methods for the treatment or prevention of inflammation
IT1318649B1 (it) 2000-07-28 2003-08-27 Propharma S R L Ora Sinclair P Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.

Also Published As

Publication number Publication date
CN1812798B (zh) 2011-02-09
EP1638582A1 (en) 2006-03-29
US10245280B2 (en) 2019-04-02
ITMI20031291A0 (it) 2003-06-25
CA2529441A1 (en) 2005-01-06
BRPI0411702B8 (pt) 2021-05-25
US20060147393A1 (en) 2006-07-06
ITMI20031291A1 (it) 2004-12-26
DE602004019528D1 (de) 2009-04-02
ES2322060T3 (es) 2009-06-16
WO2005000321A1 (en) 2005-01-06
CA2529441C (en) 2012-12-04
BRPI0411702A (pt) 2006-08-08
ATE422892T1 (de) 2009-03-15
JP2009513492A (ja) 2009-04-02
JP4728955B2 (ja) 2011-07-20
BRPI0411702B1 (pt) 2019-08-13
PT1638582E (pt) 2009-05-28
SI1638582T1 (sl) 2009-10-31
MXPA05014184A (es) 2006-03-09
EP1638582B1 (en) 2009-02-18
CN1812798A (zh) 2006-08-02
PL1638582T3 (pl) 2009-07-31
DK1638582T3 (da) 2009-05-18

Similar Documents

Publication Publication Date Title
CY1108992T1 (el) Η χρηση του υαλουρονικου οξεος για την παρασκευη συνθεσεων για τη θεραπευτικη αντιμετωπιση υποτροπιαζουσων αφθων της στοματικης κοιλοτητας
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
MXPA05011208A (es) Uso de ivermectina para el tratamiento de desordenes dermatologicos.
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
SE0101387D0 (sv) Novel compounds
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
NO20065904L (no) Terapeutiske forbindelser
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
ATE486587T1 (de) Formulierungen zur oralen verabreichung von wirkstoffen
ATE516037T1 (de) Topische formulierung von ivermectin zur behandlung von dermatologischen erkrankungen
SE0401345D0 (sv) Therapeutic compounds: Pyridine as scaffold
SE9900961D0 (sv) Novel compounds
CY1113116T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
CY1108684T1 (el) Φαρμακευτικες συνθεσεις που περιλαμβανουν ασκορβικο οξυ για τη θεραπεια μυκητοειδων υπερμολυνσεων και μυκητοειδων επανεμφανισεων
SE0302570D0 (sv) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
WO2004087700A8 (fr) Derives du benzenesulfonamide, leur procede de preparation et leur utilisation de la douleur
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
CY1105105T1 (el) Χρηση του διστροντιου αλατος του 2-[ν,ν-δι(καρβοξυμεξυλ) amino]- 3-κυανο-4-καρβοξυμεθυλ-θειοφενο-5-καρβοξυλικου οξεος για τη ληψη φαρμακων που προοριζονται για τη θεραπεια γαστρο-δωδεκαδακτυλικων πονων
CY1106129T1 (el) Κιταλοπραμη για την αγωγη της υψηλης πιεσεως του αιματος